Sign In
PROG.US
id: 1282

Progenity (PROG) Investor Settlement

The settlement terms have been submitted to the court for approval.
S.D. California
Court
3:20-cv-01683
Case number
06/22/2020
Class period Start
08/28/2020
Class period End
Progenity has reached an agreement with $PROG investors to settle claims that its IPO statement was negligently prepared, concealing $10.3M in overbilling.
Case Status
Stipulative Settlement
Alleged Offence
Mismanagement, 
Misleading Statements, 
Omissions
Suspected Party
Directors, 
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.21
Filing date
10/27/2020
Plaintiffs
Lin Shen
Defendants
Harry Stylli, Eric d’Esparbes, Jeffrey Alter, John Bigalke, Jeffrey Ferrell, Brian L. Kotzin, Samuel Nussbaum, Lynne Powell
Judge
William Q. Hayes
Administrator
Strategic Claims Services
Settlement agreement date
2024-09-19
Attorney fee
$435,833
Trades matching type
FIFO
+$1,000,000
Cash Settlement Amount

Frequently Asked Questions

When will you be able to apply for the payment?
Do I have to sell securities to be eligible?
How long does the payout process take?
What is 11thestate?

Progenity Inc

Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, inclu...

    Ticker
    PROG.US
    ISIN
    US74319F1075
    CIK
    1580063
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    4330 La Jolla Village Drive, San Diego, CA, United States, 92122